214 related articles for article (PubMed ID: 12174432)
1. [Management of monoclonal gammopathy].
Huijgens PC; Zweegman S
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1401-2. PubMed ID: 12174432
[TBL] [Abstract][Full Text] [Related]
2. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
Buiting AM; Wijermans PW
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory investigation on M-protein and its clinical application. 1. Introduction].
Itoh Y
Rinsho Byori; 2001 Jul; 49(7):675-7. PubMed ID: 11519129
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders in chronic hepatitis C.
Idilman R; Colantoni A; De Maria N; Alkan S; Nand S; Van Thiel DH
J Viral Hepat; 2004 Jul; 11(4):302-9. PubMed ID: 15230852
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
Jordan WE; Emmons R; Vogl D; Morris GJ
Semin Oncol; 2011 Jun; 38(3):327-34. PubMed ID: 21600358
[No Abstract] [Full Text] [Related]
6. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
7. Extensive thromboembolic event as initial presentation of monoclonal gammopathy of undetermined significance.
Righini M; Boehlen F; Gueddi S; Le Gal G; de Moerloose P
Thromb Haemost; 2006 Jul; 96(1):93-4. PubMed ID: 16807659
[No Abstract] [Full Text] [Related]
8. [Type I cryoglobulinemia with a fatal outcome].
Echeverría B; Vitiello M; Abuchar A; Kerdel FA
Actas Dermosifiliogr; 2011 Apr; 102(3):212-5. PubMed ID: 21376295
[TBL] [Abstract][Full Text] [Related]
9. Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance.
Grant B; Ratnayake G; Williams CL; Long A; Halsall DJ; Semple RK; Cavenagh JD; Drake WM; Church DS
Eur J Endocrinol; 2023 Dec; 189(6):K25-K29. PubMed ID: 37818852
[TBL] [Abstract][Full Text] [Related]
10. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
[TBL] [Abstract][Full Text] [Related]
11. Emerging concepts in monoclonal gammopathy of undetermined significance.
Freytes CO
Bol Asoc Med P R; 2010; 102(4):43-6. PubMed ID: 21766546
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammapathy of undetermined significance (benign monoclonal gammapathy)].
Adam Z; Tomíska M; Hájek R; Vorlícek J
Vnitr Lek; 2000 May; 46(5):286-96. PubMed ID: 11227185
[TBL] [Abstract][Full Text] [Related]
13. [Polyneuropathy associated with monoclonal serum proteins and plasma cell dyscrasias].
Smith T
Ugeskr Laeger; 1986 Oct; 148(42):2667-9. PubMed ID: 3024374
[No Abstract] [Full Text] [Related]
14. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
15. [Nephropathies in the course of plasma cell disorders].
Hanicki Z
Przegl Lek; 1995; 52(3):97-9. PubMed ID: 7644685
[No Abstract] [Full Text] [Related]
16. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
Madan S; Greipp PR
Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
[TBL] [Abstract][Full Text] [Related]
17. The Case | A patient with skin rash, monoclonal gammopathy, and proteinuria.
Fryc J; Naumnik B
Kidney Int; 2024 Mar; 105(3):643-644. PubMed ID: 38388153
[No Abstract] [Full Text] [Related]
18. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for the management of monoclonal gammopathies in biochemistry].
Oudart JB; Maquart FX; Ramont L
Ann Biol Clin (Paris); 2012; 70(3):251-61. PubMed ID: 22565172
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance: new insights.
Chen BH
CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
